| Trial ID: | L0199 |
| Source ID: | NCT05284448
|
| Associated Drug: |
Pentoxyfylline
|
| Title: |
Pentoxifylline in Treatment of Patients With Nonalcoholic Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Active, not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
NASH - Nonalcoholic Steatohepatitis
|
| Interventions: |
Drug: pentoxifylline (Trental SR??)
|
| Outcome Measures: |
improvement in liver aminotransferases(ALT and AST)|NAFLD fibrosis score (NFS)|The Aspartate (AST) to Platelet Ratio Index (APRI) score:|The Fibrosis-4 (FIB-4) values:|Serum Alkaline Phosphatase level (ALP)|Serum Gamma-glutamyl Transferase level (GGT)|Serum total and direct bilirubin.|Waist circumference|Change in anthropometric measures|Lipid profile|Glycated hemoglobin (HbA1C)|Fasting blood glucose level|Drugs adverse events
|
| Sponsor/Collaborators: |
Al-Azhar University
|
| Gender: |
All
|
| Age: |
18 Years to 65 Years ?? (Adult, Older Adult)
|
| Phases: |
Phase 3
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
February 1, 2022
|
| Completion Date: |
October 2022
|
| Results First Posted: |
--
|
| Last Update Posted: |
March 17, 2022
|
| Locations: |
Internal medicine and hepatology outpatient clinic at Ain Shams University Hospital., Cairo, Egypt
|
| URL: |
https://ClinicalTrials.gov/show/NCT05284448
|
